The global nuclear medicine radioisotopes market was valued at USD 8.90 Billion in 2024, driven by the increasing incidence of thyroid disorders. The market is expected to grow at a CAGR of 8.00% during the forecast period 2025-2034, reaching approximately USD 19.21 Billion by 2034, supported by rising diagnostic and therapeutic applications of radioisotopes. https://www.expertmarketresearch.com/reports/nuclear-medicine-radioisotopes-market